ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0591

Deficiency of FUN14 Domain-Containing Protein 1-Mediated Mitophagy in Fibroblast-like Synoviocytes Causes Aggressive Behaviors Leading to Joint Destruction in Rheumatoid Arthritis

Qian Zhang1, Tao Wu1, Jian-da Ma2, Yao-Wei Zou1, Xue-Pei Zhang1, Hu-Wei Zheng1, Jun Jing1, Yao-yao Zou3, Le-feng Chen1 and Lie Dai2, 1Sun Yat-Sen University, Guangzhou, China, 2Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, 3Guangdong People's Hospital, Guangzhou, China

Meeting: ACR Convergence 2022

Keywords: rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Synovial fibroblast-like synoviocytes (FLSs) actively participate in the pathogenesis of rheumatoid arthritis (RA). FUN14 domain-containing protein 1 (FUNDC1), a novel mitophagy receptor, plays critical roles in receptor-mediated mitophagy and participates in pathogenesis of a variety of diseases. However, the roles of FUNDC1 and FUNDC1-mediated mitophagy in RA remain unknown. Here we aimed to explore the role of FUNDC1-mediated mitophagy in RA-FLS deterioration phenotype and its clinical significance.

Methods: We observed the expression of FUNDC1 at both lining and sublining layers in RA and Orth.A synovium by immunohistochemistry. According to the median value of sublining FUNDC1 expression level, RA patients was further divided into high expression group and low expression group. Primary RA-FLS were cultured in vitro and pretreated with siNC and siFUNDC1. We measured the level of mitophagy through transmission electron microscope. Their effects on migration and invasion were detected by wound healing and transwell assays. The proteome Profiler Human Protease Array kit was used to determine the treated supernatant level.

Results: FUNDC1 expression in the sublining area of RA synovium was significantly lower than that of Orth.A (Figure 1A). RA patients with low sublining FUNDC1 expression showed significantly higher modified total Sharp score (mTSS), joint space narrowing (JSN) subscore and joint erosion (JE) subscore (Figure 1B). After FUNDC1 siRNA transfection, mitophagy decreased (Figure 2A). Besides, RA-FLSs obtained more intensive abilities of migration and invasion (Figure 2B-C). Furthermore, screening results showed that the supernatant levels of MMP1, MMP2, MMP3, cathepsin B, and cathepsin D were all significantly increased after FUNDC1 knockdown (Figure 2D).

Conclusion: Decreased expression of FUNDC1 in RA synovium was associated with radiographic joint destruction. In RA-FLSs, when FUNDC1 was knockdown, mitophagy decreased, aggravating the movability and the secretion of multiple proteases.

Supporting image 1

Figure 1. Expression of FUNDC1 in RA synovial tissue and its clinical significance
(A) Representative immunohistochemical images of synovial FUNDC1 expression. (scale bar = 100 μm – 50 μm). (B) Comparisons of joint destruction indicators between sublining FUNDC1 high/low expression groups.

Supporting image 2

Figure 2. FUNDC1 knockdown enhances the ability of migration and invasion via increased secretion of matrix metalloproteinase in RA-FLSs
(A) Representative transmission electron microscopy images showing mitophagy level in RA-FLSs after transfection of siNC or siFUNDC1 (yellow arrows: mitochondria, red arrows: autolysosomes , scale bar = 5 μm – 500 nm). (B) Wound healing assay was used for evaluation of cell motility (scale bar = 100 μm). (C) Cell migration was performed using transwell assay, 10% fetal bovine serum (FBS) was placed in the lower chamber used as chemoattractant. For invasion assay, transwell chambers were precoated with Matrigel, and FBS (15%) was placed in the lower chamber as chemoattractant (scale bar = 20 μm). (D) Cell culture supernatants were analyzed using the Proteome Profiler Human Protease Array kit after transfection of siNC or siFUNDC1.


Disclosures: Q. Zhang, None; T. Wu, None; J. Ma, None; Y. Zou, None; X. Zhang, None; H. Zheng, None; J. Jing, None; Y. Zou, None; L. Chen, None; L. Dai, None.

To cite this abstract in AMA style:

Zhang Q, Wu T, Ma J, Zou Y, Zhang X, Zheng H, Jing J, Zou Y, Chen L, Dai L. Deficiency of FUN14 Domain-Containing Protein 1-Mediated Mitophagy in Fibroblast-like Synoviocytes Causes Aggressive Behaviors Leading to Joint Destruction in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/deficiency-of-fun14-domain-containing-protein-1-mediated-mitophagy-in-fibroblast-like-synoviocytes-causes-aggressive-behaviors-leading-to-joint-destruction-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deficiency-of-fun14-domain-containing-protein-1-mediated-mitophagy-in-fibroblast-like-synoviocytes-causes-aggressive-behaviors-leading-to-joint-destruction-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology